Published in Methods Enzymol on January 01, 1981
Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A (1985) 3.46
APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog (2011) 1.90
Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun (1998) 1.85
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest (1997) 1.48
Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J Exp Med (1998) 1.43
Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha. Proc Natl Acad Sci U S A (1989) 1.36
Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J Clin Invest (1989) 1.34
Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A (1987) 1.25
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sci U S A (1986) 1.14
IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc Natl Acad Sci U S A (2009) 1.11
Regulated expression of a human interferon gene in yeast: control by phosphate concentration or temperature. Proc Natl Acad Sci U S A (1984) 1.09
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol (2015) 1.07
The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J Virol (1995) 0.99
Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein. J Virol (2005) 0.94
Structural analysis of the human interferon gamma receptor: a small segment of the intracellular domain is specifically required for class I major histocompatibility complex antigen induction and antiviral activity. Proc Natl Acad Sci U S A (1992) 0.93
The intracellular domain of interferon-alpha receptor 2c (IFN-alphaR2c) chain is responsible for Stat activation. Proc Natl Acad Sci U S A (1999) 0.92
Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors. Proc Natl Acad Sci U S A (1993) 0.91
Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity. Cytokine (2013) 0.83
Antiviral activity against transmissible gastroenteritis virus, and cytotoxicity, of natural porcine interferons alpha and beta. Can J Vet Res (1991) 0.82
A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Clin Diagn Lab Immunol (2000) 0.81
Induction of gamma-interferon activity by elevated temperatures in human B-lymphoblastoid cell lines. Proc Natl Acad Sci U S A (1984) 0.81
Localization of an antiviral site on the pregnancy recognition hormone, ovine trophoblast protein 1. Proc Natl Acad Sci U S A (1990) 0.80
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Res Ther (2011) 0.80
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases. Proc Natl Acad Sci U S A (2007) 0.80
Radiation inactivation of human gamma-interferon: cellular activation requires two dimers. Proc Natl Acad Sci U S A (1994) 0.79
Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology (2014) 0.76
Pharmacokinetic studies of the recombinant chicken interferon-α in broiler chickens. J Vet Med Sci (2016) 0.75
Interferons and their actions. Annu Rev Biochem (1987) 8.36
Human leukocyte interferon produced by E. coli is biologically active. Nature (1980) 5.86
Inhibitors of ribosome functions. Annu Rev Microbiol (1971) 5.56
Cloning and expression of murine IL-12. J Immunol (1992) 4.92
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A (1990) 4.60
Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med (1990) 3.93
Synthesis of human fibroblast interferon by E. coli. Nucleic Acids Res (1980) 3.75
Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol (1991) 3.40
Convenient assay for interferons. J Virol (1981) 2.95
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67
The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem (1999) 2.64
Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol (1995) 2.57
Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem (1982) 2.49
Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37
Insight into E-selectin/ligand interaction from the crystal structure and mutagenesis of the lec/EGF domains. Nature (1994) 2.29
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
Recombinant human interleukin 1 alpha: purification and biological characterization. J Immunol (1986) 2.24
Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells. Proc Natl Acad Sci U S A (1977) 2.12
Anti-mRNA: specific inhibition of translation of single mRNA molecules. Proc Natl Acad Sci U S A (1984) 2.06
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res (1998) 2.04
Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J (1997) 2.03
Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci U S A (1979) 2.03
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96
Induction and decay of human fibroblast interferon mRNA. Proc Natl Acad Sci U S A (1977) 1.94
Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. Proc Natl Acad Sci U S A (1980) 1.92
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med (1980) 1.91
Efficient cloning of PCR generated DNA containing terminal restriction endonuclease recognition sites. Nucleic Acids Res (1990) 1.85
Binding of [14C]erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.83
Regulatory mechanisms and protein synthesis. X. Codon recognition on 30 S ribosomes. J Mol Biol (1966) 1.76
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 3. The formation of peptide bonds by ribosomes in the absence of supernatant enzymes. J Biol Chem (1968) 1.76
Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. Antimicrob Agents Chemother (1974) 1.75
Expression and reconstitution of a biologically active human interferon-gamma receptor in hamster cells. J Biol Chem (1990) 1.70
Molecular genetic markers spanning mouse chromosome 10. Genomics (1990) 1.70
Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXIV. Effects of antibiotics on binding of aminoacyl-oligonucleotides to ribosomes. J Biol Chem (1973) 1.69
Thiostrepton: a ribosomal inhibitor of translocation. Biochem Biophys Res Commun (1970) 1.67
Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell (1994) 1.67
A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol Cell Biol (1997) 1.62
Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J Biol Chem (1981) 1.61
Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis (2000) 1.58
Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun (2000) 1.58
Studies on the formation of transfer ribonucleic acid-ribosome complexes. VI. Oligopeptide synthesis and translocation on ribosomes in the presence and absence of soluble transfer factors. J Biol Chem (1969) 1.57
Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro. Cell Immunol (1988) 1.56
Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity (1998) 1.49
Studies on transfer ribonucleic acid-ribosome complexes. XIX. Effect of antibiotics on peptidyl puromycin synthesis on polyribosoms from Escherichia coli. J Biol Chem (1972) 1.48
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci (1996) 1.42
Transfer RNA species in normal and leukemic human lymphoblasts. J Mol Biol (1970) 1.41
Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J Biol Chem (1992) 1.40
The use of inhibitors in studies on protein synthesis. Methods Enzymol (1974) 1.39
Studies on the formation of transfer ribonucleic acid-ribosome complexes. XI. Antibiotic effects on phenylalanyl-oligonucleotide binding to ribosomes. Proc Natl Acad Sci U S A (1969) 1.39
Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol (2001) 1.39
Peptidyl-puromycin synthesis on polyribosomes from Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.39
Human leukocyte interferon: isolation and characterization of several molecular forms. Arch Biochem Biophys (1981) 1.38
Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha. Proc Natl Acad Sci U S A (1989) 1.36
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol (2001) 1.35
The human interferons--from protein purification and sequence to cloning and expression in bacteria: before, between, and beyond. Arch Biochem Biophys (1983) 1.34
Thiostrepton-resistant mutants exhibit relaxed synthesis of RNA. Proc Natl Acad Sci U S A (1978) 1.33
Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.33
A cell free system reveals that capacitation is a prerequisite for membrane fusion during the acrosome reaction. FEBS Lett (1992) 1.32
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene (2000) 1.31
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 8. Survey of the effect of antibiotics of N-acetyl-phenylalanyl-puromycin formation: possible mechanism of chloramphenicol action. Arch Biochem Biophys (1970) 1.30
Amino acid sequence of a human leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.29
Cell-free synthesis of human interferon. Proc Natl Acad Sci U S A (1975) 1.29
The distance between two functionally significant regions of the 50 S Escherichia coli ribosome: the erythromycin binding site and proteins L7/L12. J Mol Biol (1976) 1.29
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci U S A (1998) 1.27
Interferon receptors. Immunol Today (1988) 1.27
Isolation and cell-free translation of immunoglobulin messenger RNA. Arch Biochem Biophys (1976) 1.26
Psychological factors in fatal childhood asthma. Am J Orthopsychiatry (1987) 1.26
Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc Natl Acad Sci U S A (1987) 1.25
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res (1985) 1.23
Studies on transfer ribonucleic acid-ribosome complexes. XXI. Effect of antibiotics on peptidyl-puromycin synthesis by mammalian polyribosomes. J Biol Chem (1972) 1.20
Studies on the formation of transfer ribonucleic acid-ribosome complexes. 23. Chloramphenicol, aminoacyl-oligonucleotides, and Escherichia coli ribosomes. J Biol Chem (1972) 1.18
Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol (2001) 1.18
Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes. Antimicrob Agents Chemother (1974) 1.16
Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. Antimicrob Agents Chemother (1976) 1.16
A single amino acid determines the immunostimulatory activity of interleukin 10. J Exp Med (2000) 1.16
Definition and classification of the interferons. Methods Enzymol (1981) 1.14
Inhibition of protein synthesis in intact HeLa cells. Antimicrob Agents Chemother (1975) 1.14
The gene for the human immune interferon receptor is located on chromosome 6. Proc Natl Acad Sci U S A (1986) 1.14
Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. J Immunol (2000) 1.13
Studies on the formation of trensfer ribonucleic acid-ribosome complexes. V. On the function of a soluble transfer factor in protein synthesis. Proc Natl Acad Sci U S A (1968) 1.13
De novo synthesis and glycosylation of the MOPC-46B mouse immunoglobulin light chain in cell-free extracts. J Biol Chem (1977) 1.12
Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer (1983) 1.12
Hsl7p, the yeast homologue of human JBP1, is a protein methyltransferase. Biochem Biophys Res Commun (2000) 1.11
Studies on the formation of transfer ribonucleic acid-ribosome complexes. II. A possible site on the 50 S subunit protecting aminoacyl transfer ribonucleic acid from deacylation. J Biol Chem (1967) 1.11
Interferon activates macrophages to produce plasminogen activator. J Interferon Res (1982) 1.11
Studies on the formation of transfer ribonucleic acid-ribosome complexes. IV. Effect of antibiotics on steps of bacterial protein synthesis: some new ribosomal inhibitors of translocation. J Biol Chem (1971) 1.10
Ribosomal protein alterations in thiostrepton- and Micrococcin-resistant mutants of Bacillus subtilis. J Biol Chem (1979) 1.09
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem (1990) 1.09